Evidence map›Paper›PMID 35573186›Full record

ArticleiScience2022

Cytoplasmic proteotoxicity regulates HRI-dependent phosphorylation of eIF2α via the Hsp70-Bag3 module.

Shivani Patel, Santosh Kumar, Simone Baldan, Arkadi Hesin, Julia Yaglom, Michael Y Sherman

Open access · goldAbstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Structural insights into HRI kinase activity and inhibition.Biochemical Society transactions · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shivani PatelLaboratory of Cancer Biology, Department of Molecular Biology, Ariel University, Ariel, 40700, Israel.
Santosh KumarLaboratory of Cancer Biology, Department of Molecular Biology, Ariel University, Ariel, 40700, Israel.
Simone BaldanLaboratory of Cancer Biology, Department of Molecular Biology, Ariel University, Ariel, 40700, Israel.
Arkadi HesinLaboratory of Cancer Biology, Department of Molecular Biology, Ariel University, Ariel, 40700, Israel.
Julia YaglomLaboratory of Cancer Biology, Department of Molecular Biology, Ariel University, Ariel, 40700, Israel.
Michael Y ShermanLaboratory of Cancer Biology, Department of Molecular Biology, Ariel University, Ariel, 40700, Israel.
Ariel University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The major heat shock protein Hsp70 forms a complex with a scaffold protein Bag3 that links it to components of signaling pathways. Via these interactions, the Hsp70-Bag3 module functions as a proteotoxicity sensor that controls cell signaling. Here, to search for pathways regulated by the complex, we utilized JG-98, an allosteric inhibitor of Hsp70 that blocks its interaction with Bag3. RNAseq followed by the pathway analysis indicated that several signaling pathways including UPR were activated by JG-98. Surprisingly, only the eIF2α-associated branch of the UPR was activated, while other UPR branches were not induced, suggesting that the response was unrelated to the ER proteotoxicity and ER-associated kinase PERK1. Indeed, induction of the UPR genes under these conditions was driven by a distinct eIF2α kinase HRI. Hsp70-Bag3 directly interacted with HRI and regulated eIF2α phosphorylation upon cytoplasmic proteotoxicity. Therefore, cytosolic proteotoxicity can activate certain UPR genes via Hsp70-Bag3-HRI-eIF2α axis.

Indexed as

Molecular biologyMolecular interactionProtein

Identifiers

PMID35573186
PMCPMC9097715
OpenAlexW4224306507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.